Botulinum toxin A injections improved wrist and finger spasticity after stroke

Hankey, Graeme J.
January 2003
ACP Journal Club;Jan/Feb2003, Vol. 138 Issue 1, p22
Academic Journal
Presents a study which investigated the role of botulinium toxin A in improving wrist and finger spasticity after stroke. Description of the clinical characteristics of patients; Patient intervention; Outcome measures.


Related Articles

  • Toxin Injections Prove Useful for Spasticity After Stroke.  // Ascribe Newswire: Medicine;8/7/2002, p3 

    Researchers are offering new hope for stroke patients suffering from spasticity of the hand with a drug that has proven effective in relieving muscle tightness or twitching in other areas of the body, according to a study. Botulinum toxin type A reduces disability caused by spasticity of the...

  • Botulinum Toxin A Treatment of Adult Upper and Lower Limb Spasticity. Hesse, S.; Brandl-Hesse, B.; Bardeleben, A.; Werner, C.; Funk, M. // Drugs & Aging;2001, Vol. 18 Issue 4, p255 

    This article discusses the treatment of spasticity with botulinum toxin A as a new approach in the neurological rehabilitation of patients after stroke. Clinical studies have been reviewed to provide information about target groups, technical aspects and the advantages and disadvantages of...

  • Botulinum Toxin in Poststroke Spasticity. Ozcakir, Suheda; Sivrioglu, Koncuy // Clinical Medicine & Research;Jun2007, Vol. 5 Issue 2, p132 

    Poststroke hemiparesis, together with abnormal muscle tone, is a major cause of morbidity and disability. Although most hemiparetic patients are able to reach different ambulatory levels with rehabilitation efforts, upper and lower limb spasticity can impede activities of daily living, personal...

  • The Underutilization of Intrathecal Baclofen in Poststroke Spasticity. Dvorak, Eric M.; Ketchum, Nicholas C.; McGuire, John R. // Topics in Stroke Rehabilitation (Thomas Land Publishers Incorpor;May/Jun2011, Vol. 18 Issue 3, p195 

    Stroke is one of the leading causes of adult disability in the United States, with a reported prevalence of 6.4 million people. Spasticity is one of the clinical features of the upper motor neuron syndrome seen after a stroke. The prevalence of spasticity after a stroke ranges from 17% to 42.6%,...

  • Stroke, Spasticity, and Botulinum Toxin. Rowland, Lewis P. // New England Journal of Medicine;8/8/2002, Vol. 347 Issue 6, p382 

    Offers observations on the use of botulinum toxin injections in patients after stroke. Cosmetic use of botulinum; Reference to an article in this issue by Brashear et al; Discussion of the extent to which disability is caused by spasticity, and why botulinum is used to treat it; Possibility that...

  • Intramuscular Injection of Botulinum Toxin for the Treatment of Wrist and Finger Spasticity after a Stroke. Brashear, Allison; Gordon, Mark F.; Elovic, Elie; Kassicieh, V. Daniel; Marciniak, Christina; Do, Mai; Lee, Chia-Ho; Jenkins, Stephen; Turkel, Catherine // New England Journal of Medicine;8/8/2002, Vol. 347 Issue 6, p395 

    Background: Spasticity is a disabling complication of stroke, and it is uncertain whether intramuscular injections of botulinum toxin type A reduce disability in persons with spasticity of the wrist and fingers after a stroke. Methods: We performed a randomized, double-blind, placebo-controlled,...

  • Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study. Simpson, M.; Gracies, J. M.; Yablon, S. A.; Barbano, R.; Brashear, A. // Journal of Neurology, Neurosurgery & Psychiatry;Apr2009, Vol. 80 Issue 4, p380 

    Background: While spasticity is commonly treated with oral agents or botulinum neurotoxin (BoNT) injection, these treatments have not been systematically compared. Methods: This study performed a randomised, double-blind, placebo-controlled trial to compare injection of BoNT-Type A into spastic...

  • Does low-dose botulinum toxin help the recovery of arm function when given early after stroke? A phase II randomized controlled pilot study to estimate effect size. Cousins, Elizabeth; Ward, Anthony; Roffe, Christine; Rimington, Lesley; Pandyan, Anand // Clinical Rehabilitation;Jun2010, Vol. 24 Issue 6, p501 

    Objective: Spasticity after stroke may be associated with worse functional outcome. Our study aim is to establish whether a low dose of botulinum toxin, given early post stroke before clinically evident spasticity warrants treatment, will improve recovery of arm function. Design: A double-blind...

  • Constraint-induced movement therapy after injection of Botulinum toxin improves spasticity and motor function in chronic stroke patients. Canning, Colleen G. // Australian Journal of Physiotherapy;2009, Vol. 55 Issue 4, p286 

    The article discusses research on the efficacy of constraint-induced movement therapy following Botulinum toxin injection in improving spasticity and motor function in chronic stroke patients. It references the study "Combined Botulinum Toxin Type A With Modified Constraint-Induced Movement...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics